Sanuwave Health receives Nasdaq approval; trading expected to start March 7 under SNWV

SANUWAVE Health, Inc.

Common stock approved for listing on Nasdaq Global Market; trading begins March 7, 2025.
Ticker 'SNWV' unchanged from OTCQB; no stockholder action required.
Board approved amended bylaws including exclusive forum, proxy rules, and director cap increase to 10.
New Code of Business Conduct and Ethics adopted effective March 4, 2025.
CEO Morgan Frank cites 'transition and progress' and expects uplisting to drive shareholder value.

item 5.03 item 5.05 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SANUWAVE Health, Inc.: Approve Amended and Restated Bylaws changing notice windows, special meeting prohibition, proxy color, board size, forum selection, and other administrative updates (effective 2025-03-04).

Change: bylaw amendment
Effective: 2025-03-04

Exact text from the filing

In connection with the Uplisting (as defined below), on March 4, 2025, the Board of Directors (the “Board”) of Sanuwave Health, Inc. (the “Company”) approved Amended and Restated Bylaws of the Company (the “A&R Bylaws”), which amend and restate the Company’s existing bylaws (the “Existing Bylaws”) in their entirety.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SANUWAVE Health, Inc.: Approved a new Code of Business Conduct and Ethics (effective 2025-03-04).

Change: code of ethics
Effective: 2025-03-04

Exact text from the filing

In connection with the Uplisting, on March 4, 2025, the Board approved a new Code of Business Conduct and Ethics.

View on SEC.gov

Browse all governance changes →

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-011275

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.